These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 20419970)
1. Role of percutaneous nephrostomy (PCN) in malignant ureteral obstruction. Jalbani MH; Deenari RA; Dholia KR; Oad AK; Arbani IA J Pak Med Assoc; 2010 Apr; 60(4):280-3. PubMed ID: 20419970 [TBL] [Abstract][Full Text] [Related]
2. The role of percutaneous nephrostomy in malignant ureteric obstruction. Wilson JR; Urwin GH; Stower MJ Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902 [TBL] [Abstract][Full Text] [Related]
3. Ureteric stents vs percutaneous nephrostomy for initial urinary drainage in children with obstructive anuria and acute renal failure due to ureteric calculi: a prospective, randomised study. ElSheemy MS; Shouman AM; Shoukry AI; ElShenoufy A; Aboulela W; Daw K; Hussein AA; Morsi HA; Badawy H BJU Int; 2015 Mar; 115(3):473-9. PubMed ID: 24698195 [TBL] [Abstract][Full Text] [Related]
4. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences? Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473 [TBL] [Abstract][Full Text] [Related]
5. The management of malignant ureteral obstruction treated with ureteral stents. Ganatra AM; Loughlin KR J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous nephrostomy for ureteric obstruction due to advanced pelvic malignancy: have we got the balance right? Misra S; Coker C; Richenberg J Int Urol Nephrol; 2013 Jun; 45(3):627-32. PubMed ID: 23666587 [TBL] [Abstract][Full Text] [Related]
7. Wire-reinforced ureteral stents to rescue from nephrostomy tube in extrinsic ureteral obstruction. Dauw CA; Faerber GJ; Hollingsworth JM; Wolf JS Can J Urol; 2015 Jun; 22(3):7806-10. PubMed ID: 26068630 [TBL] [Abstract][Full Text] [Related]
8. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients. Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474 [TBL] [Abstract][Full Text] [Related]
9. Clinical Factors Associated With a Short Survival Time After Percutaneous Nephrostomy for Ureteric Obstruction in Cancer Patients: An Updated Model. Alawneh A; Tuqan W; Innabi A; Al-Nimer Y; Azzouqah O; Rimawi D; Taqash A; Elkhatib M; Klepstad P J Pain Symptom Manage; 2016 Feb; 51(2):255-61. PubMed ID: 26497918 [TBL] [Abstract][Full Text] [Related]
10. Nephrostomy insertion for patients with bilateral ureteric obstruction caused by prostate cancer. Nariculam J; Murphy DG; Jenner C; Sellars N; Gwyther S; Gordon SG; Swinn MJ Br J Radiol; 2009 Jul; 82(979):571-6. PubMed ID: 19153185 [TBL] [Abstract][Full Text] [Related]
11. Ultrasound guided percutaneous nephrostomy for obstructive uropathy in benign and malignant diseases. Sood G; Sood A; Jindal A; Verma DK; Dhiman DS Int Braz J Urol; 2006; 32(3):281-6. PubMed ID: 16813670 [TBL] [Abstract][Full Text] [Related]
12. [Percutaneous drainage nephrostomy in patients over 70 years of age. Apropos of 98 nephrostomies in 74 patients]. Fournier G; Delavierre D; Le Coat R; Philippe P; Mangin P Prog Urol; 1994 Jun; 4(3):362-70. PubMed ID: 8044179 [TBL] [Abstract][Full Text] [Related]
13. Survival time and period of catheterization in patients treated with percutaneous nephrostomy for urinary obstruction due to malignancy. Radecka E; Magnusson M; Magnusson A Acta Radiol; 2006 Apr; 47(3):328-31. PubMed ID: 16613316 [TBL] [Abstract][Full Text] [Related]
14. Complications of percutaneous nephrostomy in the treatment of malignant ureteral obstructions: single-centre review. Carrafiello G; Laganà D; Mangini M; Lumia D; Recaldini C; Bacuzzi A; Marconi A; Mira A; Cuffari S; Fugazzola C Radiol Med; 2006 Jun; 111(4):562-71. PubMed ID: 16779542 [TBL] [Abstract][Full Text] [Related]
15. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases. Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous nephrostomy in the management of advanced and terminal-stage gynecologic malignancies: outcome and complications. Plesinac-Karapandzic V; Masulovic D; Markovic B; Djuric-Stefanovic A; Plesinac S; Vucicevic D; Milovanovic Z; Milosevic Z Eur J Gynaecol Oncol; 2010; 31(6):645-50. PubMed ID: 21319508 [TBL] [Abstract][Full Text] [Related]
17. Emergent ureteric stent vs percutaneous nephrostomy for obstructive urolithiasis with sepsis: patterns of use and outcomes from a 15-year experience. Goldsmith ZG; Oredein-McCoy O; Gerber L; Bañez LL; Sopko DR; Miller MJ; Preminger GM; Lipkin ME BJU Int; 2013 Jul; 112(2):E122-8. PubMed ID: 23795789 [TBL] [Abstract][Full Text] [Related]
18. Ultrasound guided percutaneous nephrostomy: Experience at ahmadu bello university teaching hospital, Zaria. Ahmed M; Lawal AT; Bello A; Sudi A; Awaisu M; Muhammad S; Oyelowo N; Tolani M; Hamza BK; Maitama HY Niger J Clin Pract; 2017 Dec; 20(12):1622-1625. PubMed ID: 29378997 [TBL] [Abstract][Full Text] [Related]
19. Prompt management of anastomotic leak or acute obstruction after minimally invasive pyeloplasty with percutaneous nephrostomy preserves outcomes. Ozayar A; Morgan MS; Friedlander JI; Saumur M; Krishan G; Gahan JC; Cadeddu JA J Urol; 2014 Dec; 192(6):1716-9. PubMed ID: 24952241 [TBL] [Abstract][Full Text] [Related]
20. The role of percutaneous nephrostomy in malignant urinary tract obstruction. Watkinson AF; A'Hern RP; Jones A; King DM; Moskovic EC Clin Radiol; 1993 Jan; 47(1):32-5. PubMed ID: 8428414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]